Skip to content

Clinical trials

Phase 1 Mental Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Phase: Phase 1 Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20061
20074
20083
20093
20102
20115
20125
20131
20141
20152
20161
20173
20182
20192
20203
20214
20223
20231
20245
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Terminated6
Recruiting5
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Luye Pharma Group Ltd.5
GlaxoSmithKline4
Yale University4
Otsuka Pharmaceutical Development & Commercialization, Inc.3
National Institute on Drug Abuse (NIDA)2
Oregon Research Institute2
Siena Biotech S.p.A.2
Alzheimer's Disease Expert Lab (ADEL), Inc.1
Brigham and Women's Hospital1
Bristol-Myers Squibb1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders57
Schizophrenia11
Mood Disorders9
Major Depressive Disorder8
Substance-Related Disorders8
Brain Diseases7
Depressive Disorder6
Central Nervous System Diseases5
Dementia5
Nervous System Diseases5

Trials

Showing 51 to 57 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.